| Particulars |
|
|
|
| Company Name
| Astrazeneca Pharma India Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
5.00 |
B.V. (₹) |
319.60 |
| Sales(₹ Cr.) |
1,716.29 |
NP (₹ Cr.) |
175.13 |
| NP Var (%) |
17.00 |
Div% |
1,600.00 |
| CPS(₹) |
86.00 |
EPS (₹) |
70.10 |
| Traded Value(₹ Lakhs) |
9.42 |
52 Week High |
10,653.00 |
| 52 Week Low |
6,301.00 |
Price BSE |
9,138.00 |
| Price NSE |
9,155.00 |
Market Capital (₹ Cr.) |
22,845.88 |
| P/C Ratio |
106.20 |
P/E Ratio |
130.40 |
| Price Vs.BV |
28.59 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
559.09 |
| NP(₹ Cr.) |
58.13 |
NP Var % |
51.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
1,484.51 |
| OPM |
9.59 |
NP |
128.73 |
| NP Var (%) |
79.57 |
EPS |
92.47 |
| PE |
98.83 |
|
|